期刊文献+

依达拉奉对大鼠心肌再灌注损伤的保护作用及机制 被引量:1

The protective effect and mechanism of edaravone against myocardium reperfusion injury in rats
在线阅读 下载PDF
导出
摘要 目的探讨自由基清除剂依达拉奉对大鼠心肌再灌注损伤的保护作用及机制。方法将造模成功的24只Wistar大鼠随机分为对照组、缺血再灌注组(再灌注组)、保护组,每组8只。实验结束后检测各组大鼠血清肌酸激酶同工酶(CK-MB)、谷胱甘肽过氧化物酶(GSH-PX)活性及丙二醛水平;光学显微镜观察心肌形态;采用TUNEL和免疫组织化学法分别检测心肌细胞凋亡及心肌凋亡蛋白Bcl-2、Bax的表达。结果与对照组比较,再灌注组大鼠CK MB、丙二醛水平明显升高,GSH-PX活性明显降低,Bcl-2、Bax、Bax/Bcl-2明显升高(P<0.01);与再灌注组比较,保护组大鼠CK-MB、丙二醛水平明显降低,GSH-PX活性明显升高,Bcl-2明显升高,Bax、Bax/Bcl-2明显降低(P<0.01)。与保护组比较,再灌注组大鼠可见大面积心肌梗死,凋亡细胞数明显增加(P<0.01)。结论依达拉奉能够减轻大鼠心肌损伤程度,其机制与减少自由基损伤、抑制心肌细胞凋亡有关。 Objective To investigate the protective effect and mechanism of edaravone against myocardium reperfusion injury in rats.Methods Twenty-four Wistar rats were randomly divided into control group,ischemia-reperfusion group and protective group.After experiment,the activity of CK-MB,GSHPX and concentration of MDA were detected.The myocardial morphology was observed with light microscope.TUNEL staining and immunohistochemical methods were used to determine apoptosis of myocardial cells and expression of Bcl-2 and Bax proteins.Results The activity of serum CK-MB and MDA were higher and the activity of GSHPX was lower in ischemiareperfusion group than in control group.The activity of serum CK-MB and content of MDA were lower and the activity of GSHPX was higher in protective group than in ischemiareperfusion group.There was large area of myocardial infarction in ischemiareperfusion group;but the myocardial injury was lighter in protective group.Apoptotic cells was less in protective group than in ischemiareperfusion group.Bcl-2,Bax protein and the ratio of Bax/Bcl-2 were significantly higher in ischemiareperfusion group than in control group(P〈0.01),the expression of protein Bcl-2 was significantly higher in protective group than in ischemiareperfusion group(P〈0.01),but the expression of protein Bax and ratio of Bax/Bcl-2 were significantly lower in protective group than in ischemiareperfusion group,and was higher in ischemiareperfusion group than in control group.Conclusions Edaravone can reduce the extent of myocardial injury,the mechanism is concerned with reducing free radical damage and inhibiting myocardial cell apoptosis.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2010年第8期729-732,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 哈尔滨市青年基金(2003AFQXJ039)
关键词 自由基清除剂 心肌再灌注损伤 肌酸激酶 细胞凋亡 谷胱甘肽过氧化酶 心肌 free radical scavengers myocardial reperfusion injury creatine kinase apoptosis glutathione peroxidase myocardium
  • 相关文献

参考文献12

  • 1王淑侠,兰小莉,王吉文,裴著果.大鼠心肌缺血/再灌注损伤模型的改进与评价[J].解剖科学进展,2000,6(4):371-373. 被引量:76
  • 2贾新未,魏盟.氧化应激与血管内皮功能异常[J].国际心血管病杂志,2006,33(2):104-107. 被引量:5
  • 3伍静,姚尚龙.活性氧与心肌缺血/再灌注损伤诱发的细胞凋亡[J].国外医学(麻醉学与复苏分册),2002,23(2):119-122. 被引量:4
  • 4Lee MJ,Kwak YK,You KR, et al. Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury. Exp Mol Med, 2009,41 : 243-252.
  • 5Shirito K,Otani H, Yamamoto F, et al. MK2-/- gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia-reperfusion injury. J Mol cell Cardiol, 2005, 38: 93-97.
  • 6Shi H. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem, 2009,16 : 4593-4600.
  • 7Yoshida H, Metoki N, Ishikawa A. Edaravone improves the expression of nerve growth factor in human astrocytes subjected to hypoxia/reoxygenation. Neurosci Res, 2010, 66: 284- 289.
  • 8Yamamura M, Mitsuno M, Tanaka H, et al. Edaravone suppresses enclothelial cell injury in vein grafts of a rat model. Int J Angiol, 2008,17 : 221-222.
  • 9Rajesh KG,Sasaguri S,Suzuki R,et al. Antioxidant MCI-186 inhibits mitoehondrial permeability transition pore and upregulates Bcl-2 expression. Am J Physiol Heart Circ Physiol, 2003,285 : H2171-H2178.
  • 10Zhang G, Matsumoto S, Hyon SH, et al. Polyphenol, an extract of green tea,increases culture recovery rates of isolated islets from nonhuman primate pancreata and marginal grade human pancreata. Cell Transplant, 2004,13 : 145-152.

二级参考文献23

  • 1[1]Irani K.Oxidant signaling in vascular cell growth,death,and survival:a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling[J].Circ Res,2000,87(3):179-183.
  • 2[2]Fenster BE,Tsao S,Rockson SG,et al.Endothelial dysfunction:Clinical strategies for treating oxidant stress[J].Am Heart J,2003,146(2):216-226.
  • 3[3]Wang HD,Xu S,Johns DG,et al.Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin Ⅱ in mice[J].Circ Res,2001,88(9):947-953.
  • 4[4]Azumi H,Inoue N,Takeshita S,et al.Expression of NADH/NADPH oxidase p22phox in human coronary arteries[J].Circulation,1999,100(14):1494-1498.
  • 5[5]Cahilly C,Ballantyne CM,Lim DS,et al.A variant of p22 (phox) involved in generation of reactive oxygen species in the vessel wall,is associated with progression of coronary atheroscelerosis[J].Circ Res,2000,86(3):391-395.
  • 6[6]Heitzer T,Brockhoff C,Mayer B,et al.Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers:evidence for a dysfunctional nitric oxide synthase[J].Circ Res,2000,86(2):E36-E41.
  • 7[7]Mervaala EM,Cheng ZJ,Tikkanen I,et al.Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes[J].Hypertension,2001,37(2 Part2):414-418.
  • 8[8]Butler R,Morris AD,Belch JJ,et al.Allopurinol mormalizes endothelial dysfunction in type 2 diabetics with mild hypertension[J].Hypertension,2000,35(3):746-751.
  • 9[9]Mather KJ,Verma S,Anderson TJ,et al.Improved endothelial function with metformin in type 2 diabetes mellitus[J].J Am Coll Cardiol,2001,37(5):1344-1350.
  • 10[10]Salonen RM,Nyyssonen K,Kaikkonen J,et al.Six year effect of combined vitamin C and E supplementation on atherosclerotic progression:the antioxidant supplementation in atherosclerosis prevention (ASAP) study[J].Circulation,2003,107(7):947-953.

共引文献82

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部